General Information of DTT (ID: TTNA5ZS)

DTT Name Cholesterol absorption (Chole absorp) DTT Info
Gene Name Chole absorp

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Discontinued Drug(s)
Clinical Trial Drug(s)
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
KT6-971 DM08F12 Hypercholesterolaemia 5C80.0 Phase 2 [1]
MD-0727 DM5DSGJ Hypercholesterolaemia 5C80.0 Phase 2 [2]
------------------------------------------------------------------------------------
2 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
SCH-48461 DM28AFU Hyperlipidaemia 5C80 Discontinued in Phase 2 [3]
Tiqueside DMUJ2X6 Hyperlipidaemia 5C80 Discontinued in Phase 2 [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Intestinal and Hepatic Niemann-Pick C1-Like 1. Correction in: Diabetes Metab J. 2013 December; 37(6): 486-487.
2 Th-P16:297 Early clinical characterization of MD-0727, a novel cholesterol absorption inhibitor, in healthy subjects. Atherosclerosis Supplements Volume 7, Issue 3, 2006, Pages 558-559.
3 Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461. Atherosclerosis. 1995 May;115(1):45-63.
4 Inhibiting cholesterol absorption with CP-88,818 (beta-tigogenin cellobioside; tiqueside): studies in normal and hyperlipidemic subjects. J Cardiovasc Pharmacol. 1997 Jul;30(1):55-60.